Collegium Pharmaceutical, Inc (COLL) stock
COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/3045% below fair value
$24.81+0.34 (+1.39%)
Close on Nov 11, 2026Market cap $807.71MP/E 24.8Yield –
Collegium Pharmaceutical statistics
99 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 11, 2026
Valuation ratiosIndustry
- P/OCF Ratio
- 2.39
- 13.11
Enterprise valuationIndustry
- EV / Sales
- 0.81
- 2.65
- EV / EBIT
- 5.34
- 19.03
- EV / FCF
- 1.97
- 22.15
Share statisticsIndustry
- Shares Change (YoY)
- 0.16%
- 10.9%
- Shares Change (QoQ)
- -4.39%
- 0.51%
- Float
- 31M
- 49M
- Shares Held by Insiders
- 4.32%
- 11.6%
- Shares Held by Institutions
- 121.2%
- 56.4%
Short sellingIndustry
- Short Interest
- 5M
- –
- Short Interest Change
- -3.36%
- -0.76%
- Short % of Float
- 16.7%
- 9.06%
- Short % of Shares Outstanding
- 16.0%
- 6.38%
- Days to Cover
- 9.40
- 5.16
Stock price statisticsIndustry
- 52-Week High
- $50.79
- –
- 52-Week Low
- $21.43
- –
- 20-Day Moving Average
- $23.68
- –
- 50-Day Moving Average
- $22.99
- –
- 200-Day Moving Average
- $32.35
- –
- Average True Range (14)
- $0.97
- –
- Price Change (1 Week)
- 4.82%
- -0.50%
- Price Change (1 Month)
- 15.2%
- -0.33%
- Price Change (3 Months)
- -11.9%
- -17.2%
- Price Change (6 Months)
- -28.8%
- -20.1%
- Price Change (YTD)
- -46.4%
- -20.1%
- Price Change (1 Year)
- -43.0%
- -19.3%
- Price Change (3 Years)
- 1.35%
- -23.4%
- Price Change (5 Years)
- 27.4%
- -76.4%
- Price Change (10 Years)
- 41.8%
- -62.4%
- Average Volume (10 Days)
- 731,846
- –
- Average Volume (20 Days)
- 671,087
- –
- Average Volume (90 Days)
- 722,529
- –
- Relative Volume
- 0.69
- 0.73
- Relative Strength Index (14)
- 60.4
- 47.6
- Volatility (1 Year)
- 42.2%
- 80.2%
- Beta (5 Years)
- 0.46
- 1.07
MarginsIndustry
- Pretax Margin
- 5.17%
- -12.1%
- EBITDA Margin
- 15.2%
- -25.0%
- FCF Margin
- 41.3%
- -9.55%
Returns on capitalIndustry
- Return on Equity (ROE)
- 13.4%
- -51.3%
- Return on Assets (ROA)
- 2.06%
- -40.3%
- Return on Invested Capital (ROIC)
- 159.8%
- -34.0%
- Return on Capital Employed (ROCE)
- 8.31%
- -37.7%
Financial positionIndustry
- Current Ratio
- 1.01
- 3.30
- Quick Ratio
- 0.76
- 2.37
- Interest Coverage
- 1.62
- -6.27
GrowthIndustry
- Revenue Growth (YoY)
- 7.68%
- 7.01%
- Net Income Growth (YoY)
- -34.7%
- -24.7%
- EPS Growth (YoY)
- -37.9%
- -12.8%
- FCF Growth (YoY)
- 16.2%
- 6.85%
- Revenue Growth (3Y CAGR)
- 18.9%
- 2.25%
- Revenue Growth (5Y CAGR)
- 20.3%
- 6.41%
- EPS Growth (5Y CAGR)
- 17.9%
- 3.77%
EfficiencyIndustry
- Asset Turnover
- 0.44
- 0.40
- Inventory Turnover
- 5.29
- 2.68
- Revenue Per Employee
- $1.93M
- $426.63K
- Profits Per Employee
- $90.23K
- -$680.86K
- Employee Count
- 423
- 75
- WACC
- 7.38%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- $42.15M
- -$13.50M
Balance sheetIndustry
- Net Cash (Debt)
- $144.80M
- $16.31M
- Net Cash Per Share
- $4.45
- $0.70
- Equity (Book Value)
- $296.44M
- $53.12M
- Book Value Per Share
- $9.11
- $1.49
- Tangible Book Value
- -$1.03B
- $26.11M
- Working Capital
- $8.67M
- $77.59M
Cash flow (TTM)Industry
- Capital Expenditures
- -$1.73M
- -$939.00K
- FCF Per Share
- $10.33
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 4.73%
- -19.8%
- FCF Yield
- 41.6%
- -8.81%
Taxes and interestIndustry
- Interest Expense
- $76.62M
- $2.98M
- Income Tax
- $3.98M
- $79.50K
- Effective Tax Rate
- 9.45%
- 20.7%
Scores and fair valueIndustry
- Graham Number
- $14.31
- $19.42
- Graham Upside
- -42.3%
- -45.8%
- Altman Z-Score
- 0.81
- 0.28
- Piotroski F-Score
- 6
- 4
- Lynch Fair Value
- $17.88
- –
- Lynch Upside
- -27.9%
- -27.9%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | COLL | S&P 500 | Difference | COLL per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +12.3% | -2.4% | +14.7 pts | ||
| 3 months | -4.5% | -1.2% | −3.4 pts | ||
| Year to date | -46.4% | +12.3% | −58.7 pts | ||
| 1 year | -44.7% | +12.4% | −57.1 pts | ||
| 3 years | +1.3% | +78.8% | −77.5 pts | +0.4% | +21.4% |
| 5 years | +23.3% | +75.2% | −51.9 pts | +4.3% | +11.9% |
| 10 years | +41.8% | +311.1% | −269.3 pts | +3.6% | +15.2% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
5M COLL shares were sold short on Oct 30, 2026, down 3.4% from the previous report, or 16.68% of the shares available to trade. At recent volumes it would take 9.4 days to buy them back. Over the last 20 sessions, 52.1% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 5,194,875 | -3.4% | 552,891 | 9.4 |
| Oct 15, 2026 | 5,375,283 | -2.6% | 749,870 | 7.2 |
| Sep 30, 2026 | 5,516,880 | -2.8% | 910,922 | 6.1 |
| Sep 15, 2026 | 5,675,115 | -6.4% | 941,430 | 6.0 |
| Aug 31, 2026 | 6,063,781 | -7.0% | 750,635 | 8.1 |
| Aug 14, 2026 | 6,523,302 | +28.4% | 979,471 | 6.7 |
| Jul 31, 2026 | 5,080,634 | -2.9% | 292,836 | 17.4 |
| Jul 15, 2026 | 5,233,514 | -4.3% | 467,575 | 11.2 |
| Jun 30, 2026 | 5,466,533 | +2.6% | 504,462 | 10.8 |
| Jun 15, 2026 | 5,328,343 | -5.9% | 407,626 | 13.1 |
| May 29, 2026 | 5,664,249 | -5.0% | 318,273 | 17.8 |
| May 15, 2026 | 5,965,080 | +0.5% | 533,619 | 11.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?